Literature DB >> 19148676

Seroepidemiological study in a Puumala virus outbreak area in South-East Germany.

Marc Mertens1, Roman Wölfel, Katrin Ullrich, Kumiko Yoshimatsu, Jana Blumhardt, Ina Römer, Jutta Esser, Jonas Schmidt-Chanasit, Martin H Groschup, Gerhard Dobler, Sandra S Essbauer, Rainer G Ulrich.   

Abstract

Puumala virus (PUUV) is the cause of the majority of haemorrhagic fever with renal syndrome cases in Germany. In 2004, a nephropathia epidemica outbreak was recorded in Lower Bavaria, South-East Germany. For a seroepidemiological study in this region including the resident population at four locations (n = 178) and soldiers from one location (n = 208) indirect immunoglobulin M (IgM) and immunoglobulin G (IgG) enzyme-linked immunosorbent assays (ELISAs) and immunoblot tests based on a yeast-expressed PUUV nucleocapsid protein were established. The validation using human serum panels originating from Germany revealed a diagnostic sensitivity and specificity of 98/100% for the IgM ELISA, 99/99% for the IgG ELISA, 99/100% for the IgM immunoblot test and 100/96% for the IgG immunoblot test. Using the novel IgG assays as well as a commercial IgG ELISA and an immunofluorescence assay for the resident population an average prevalence of 6.7% (12 of 178) with a range of 0% (0 of 21) to 11.9% (7 of 59) was observed. Positive serological results were equally distributed between males and females with an average age of 63 for males and 52 for females. The seroprevalence in the soldier group was found to be about 1% with one positive male of 203 (age 46 years) and one positive female of five (age 47 years). In conclusion, the PUUV seroprevalence in the residents of the outbreak region in Lower Bavaria was found to be up to fivefold higher than the average hantavirus seroprevalence of the German population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148676     DOI: 10.1007/s00430-009-0106-9

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  34 in total

1.  Larger than usual increase in cases of hantavirus infections in Belgium, France and Germany, June 2005.

Authors:  Alexandra Mailles; Muna Abu Sin; Geneviève Ducoffre; Paul Heyman; Judith Koch; Hervé Zeller
Journal:  Euro Surveill       Date:  2005-07-21

2.  [Endemic occurrence of hemorrhagic fever with renal syndrome in the Federal Republic of Germany].

Authors:  J Pilaski; C Ellerich; T Kreutzer; W Benik; B Lewandowski; A Lang; I B Autenrieth; E Vanek
Journal:  Z Arztl Fortbild (Jena)       Date:  1991-09-25

3.  Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay.

Authors:  L Zöller; M Faulde; H Meisel; B Ruh; P Kimmig; U Schelling; M Zeier; P Kulzer; C Becker; M Roggendorf
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

4.  Hantavirus outbreak during military manoeuvres in Germany.

Authors:  J Clement; P Underwood; D Ward; J Pilaski; J LeDuc
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321

5.  Nephropathia epidemica and Puumala virus in Austria.

Authors:  S W Aberle; P Lehner; M Ecker; J H Aberle; K Arneitz; G Khanakah; A Radda; I Radda; T Popow-Kraupp; C Kunz; F X Heinz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-07       Impact factor: 3.267

6.  Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome.

Authors:  H Feldmann; A Sanchez; S Morzunov; C F Spiropoulou; P E Rollin; T G Ksiazek; C J Peters; S T Nichol
Journal:  Virus Res       Date:  1993-12       Impact factor: 3.303

7.  Nephropathia epidemica: incidence of clinical cases and antibody prevalence in an endemic area of Sweden.

Authors:  B Niklasson; J Leduc; K Nyström; L Nyman
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

8.  Patterns of Puumala virus infection in Finland.

Authors:  A M C Rose; O Vapalahti; O Lyytikäinen; P Nuorti
Journal:  Euro Surveill       Date:  2003-01

Review 9.  Hantavirus infections in Europe.

Authors:  Olli Vapalahti; Jukka Mustonen; Ake Lundkvist; Heikki Henttonen; Alexander Plyusnin; Antti Vaheri
Journal:  Lancet Infect Dis       Date:  2003-10       Impact factor: 25.071

10.  Nephropathia epidemica in metropolitan area, Germany.

Authors:  Sandra S Essbauer; Jonas Schmidt-Chanasit; Ernst L Madeja; Wolfgang Wegener; Robert Friedrich; Rasa Petraityte; Kestutis Sasnauskas; Jens Jacob; Judith Koch; Gerhard Dobler; Franz J Conraths; Martin Pfeffer; Christian Pitra; Rainer G Ulrich
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more
  16 in total

Review 1.  Recent publications in medical microbiology and immunology: a retrospective.

Authors:  H W Doerr; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

2.  Serosurvey of Crimean-Congo Hemorrhagic Fever Virus in Cattle, Mali, West Africa.

Authors:  Ousmane Maiga; Miriam Andrada Sas; Kyle Rosenke; Badian Kamissoko; Marc Mertens; Nafomon Sogoba; Abdallah Traore; Modibo Sangare; Mamadou Niang; Tom G Schwan; Hamidou Moussa Maiga; Sekou F Traore; Heinz Feldmann; David Safronetz; Martin H Groschup
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

3.  Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava-Belgrade hantaviruses.

Authors:  Marc Mertens; Jörg Hofmann; Rasa Petraityte-Burneikiene; Mario Ziller; Kestutis Sasnauskas; Robert Friedrich; Olaf Niederstrasser; Detlev H Krüger; Martin H Groschup; Eckhardt Petri; Sandra Werdermann; Rainer G Ulrich
Journal:  Med Microbiol Immunol       Date:  2011-05-25       Impact factor: 3.402

Review 4.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Phylogenetic analysis of Puumala virus subtype Bavaria, characterization and diagnostic use of its recombinant nucleocapsid protein.

Authors:  Marc Mertens; Eveline Kindler; Petra Emmerich; Jutta Esser; Christiane Wagner-Wiening; Roman Wölfel; Rasa Petraityte-Burneikiene; Jonas Schmidt-Chanasit; Aurelija Zvirbliene; Martin H Groschup; Gerhard Dobler; Martin Pfeffer; Gerald Heckel; Rainer G Ulrich; Sandra S Essbauer
Journal:  Virus Genes       Date:  2011-05-20       Impact factor: 2.332

6.  Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs.

Authors:  Paul Dremsek; Jürgen J Wenzel; Reimar Johne; Mario Ziller; Jörg Hofmann; Martin H Groschup; Sandra Werdermann; Ulrich Mohn; Silvia Dorn; Manfred Motz; Marc Mertens; Wolfgang Jilg; Rainer G Ulrich
Journal:  Med Microbiol Immunol       Date:  2011-12-18       Impact factor: 3.402

7.  In Search for Factors that Drive Hantavirus Epidemics.

Authors:  Paul Heyman; Bryan R Thoma; Jean-Lou Marié; Christel Cochez; Sandra Simone Essbauer
Journal:  Front Physiol       Date:  2012-07-10       Impact factor: 4.566

8.  Validation of the Puumala virus rapid field test for bank voles in Germany.

Authors:  D Reil; C Imholt; U M Rosenfeld; S Drewes; S Fischer; E Heuser; R Petraityte-Burneikiene; R G Ulrich; J Jacob
Journal:  Epidemiol Infect       Date:  2016-11-03       Impact factor: 4.434

9.  Identification of factors influencing the Puumala virus seroprevalence within its reservoir in aMontane Forest Environment.

Authors:  Bryan R Thoma; Jörg Müller; Claus Bässler; Enrico Georgi; Anja Osterberg; Susanne Schex; Christian Bottomley; Sandra S Essbauer
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

10.  Development of an immunochromatography strip test based on truncated nucleocapsid antigens of three representative hantaviruses.

Authors:  Takako Amada; Kumiko Yoshimatsu; Takaaki Koma; Kenta Shimizu; Chandika D Gamage; Kanae Shiokawa; Sanae Nishio; Clas Ahlm; Jiro Arikawa
Journal:  Virol J       Date:  2014-05-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.